Famotidine 20 mg in 50 mL Injection
RxNorm 199739
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 199739 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: famotidine 20 mg in 50 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
50 mL famotidine 0.4 mg/ML Injection
(Atom ID: 12349735)
PSNPrescribable
Prescribable Name (PSN):
Famotidine 20 mg in 50 mL Injection
(Atom ID: 7746328)
SYPrescribable
Synonym (SY):
Famotidine 20 mg per 50 mL Injection
(Atom ID: 7746329)
Patient Education
Famotidine Injection
Famotidine injection is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid or to treat ulcers (sores in the lining of the stomach or intestine) that were not successfully treated with other medications. Famotidine injection is also used on a short-term basis in people who cannot take oral medication to treat ulcers, to prevent ulcers from returning after they have healed, to treat gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube between the throat and the stomach]), and to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas and small intestine that caused increased production of stomach acid). Famotidine injection is in a class of medications called H2 blockers. It works by decreasing the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.